Sort
21,453 grants matching “tuberculosis”
Population Based Molecular Epidemiology of TB
$993,463University Of California San Francisco · R01 · FY2001 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$993,273Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
SDMC: HIV Vaccine Trials Network
$992,886Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
Teixobactin Development for Anthrax
$992,770Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2022 · AI
DOT Diary (D2): Developing a mobile app with combined automated DOT and daily sexual diary for monitoring and improving PrEP adherence
$992,570Susan Buchbinder · Public Health Foundation Enterprises · R01 · FY2017 · MH
Teixobactin Development for Tuberculosis
$992,480Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2024 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children
$992,134Molly Forrest Franke · Harvard Medical School · U19 · FY2016 · AI
SDMC: HIV Vaccine Trials Network
$991,756Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2025 · AI
BCG overexpressing a small molecule STING agonist as a vaccine for TB
$991,112Todd Wallach · Oncosting Llc · R44 · FY2025 · AI
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$990,912Robert A Salata · Case Western Reserve University · U54 · FY2021 · CA
Clinical Studies
$990,352Megan B Murray · Harvard Medical School · U19 · FY2022 · AI
Gerome Wide Association Study of Bacterial Determinants of Clinical Response in Tuberculosis
$990,349Megan B Murray · Harvard Medical School · U19 · FY2022 · AI
Establishing the Genetic Basis of Altered Drug Responses in Mycobacterium tuberculosis
$990,348Sarah M Fortune · Harvard Medical School · U19 · FY2022 · AI
Clinical Core
$990,212Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2018 · AI
LPS Signaling in Macrophages: The Roll of Toll
$990,128Alan A Aderem · Seattle Biomedical Research Institute · R01 · FY2016 · AI
LPS Signaling in Macrophages: The Roll of Toll
$990,128Alan A Aderem · Seattle Biomedical Research Institute · R01 · FY2017 · AI
Broad-Spectrum Antimicrobials Targeting the D-Alanine Pathway
$989,745Karen G. Anthony · L2 Diagnostics, Llc · U01 · FY2010 · AI
Ototoxicity of modified aminoglycosides
$989,230Sandra Paige Story · Nubad, Llc · R44 · FY2022 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$989,186Chetan Seshadri · University Of Washington · R01 · FY2025 · AI
Development of Coccidioides Cytokine Release Assay
$988,914Eric Holbrook · Miravista Diagnostics, Llc · R44 · FY2025 · AI
Bloodstream infection detection directly on whole blood
$988,666Alfredo Andres Celedon · Scanogen, Inc. · R44 · FY2022 · AI
Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculosis
$988,293Michelle M. Butler · Microbiotix, Inc · R44 · FY2015 · AI
TULANE NATINAL PRIMATE RESEARCH CENTER
$988,254Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2007 · RR
Clinical Core
$988,221Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
Xenobiotic Receptors
$988,205Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA